A carregar...

RATIONALE FOR ASPREE DISABILITY-FREE SURVIVAL PRIMARY OUTCOME AND OVERVIEW OF PRIMARY OUTCOME RESULTS

Disability-free survival (DFS), defined as survival free of disability and dementia was the primary outcome measure of the ASPREE clinical trial. As previously reported, there was no benefit of low dose aspirin on the primary end point of dementia, physical disability or death, but bleeding risks we...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Innov Aging
Autor principal: McNeil, John
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6841267/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/geroni/igz038.2357
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!